A leading evidence-based medicine (EBM) guidelines publisher announces the publication of the very first EBM Coronavirus (COVID-19) Guideline for occupational health. The announcement comes at a critical time as state jurisdictions fight to mitigate the pandemic’s effects on their respective economies and workforces. This is an important publication as it establishes an objective starting point for occupational health providers to consider.
State Workers’ Compensation Standards
California’s Assembly Insurance Committee is having a public hearing on AB 1107 on Wednesday April 24th. Is the bill a step in the right direction in promoting prompt, adequate medical treatment for injured workers in the State of California? Fortunately, we have a material amount of data to help inform the answer to this question. Here is my take on the issue.
Irrespective of overwhelmingly positive data published on appropriate UR decisions, the UR process becomes a target of criticism. Largely driven by a lack of understanding, a push to unravel this layer of protection for injured workers persists. The overutilization of unnecessary medical care is not a benefit, it is a risk. Here are my thoughts on how the King case may motivate this movement come next year’s legislative session.
Tragedy has a way of spurring unexpected outcomes bringing people together from all walks of life and disciplines. Here are my observations on the paradigm shifts happening throughout workers’ compensation partly due to the global tragedy that is the opioid epidemic.
Another important July 1st deadline has come and gone for the California workers’ compensation community. As of mid-June, nearly half of California’s Utilization Review Organizations had yet to complete the accreditation process required by newly modified Labor Code section 4610(g)(4). Is the crawl to compliance due to a complacent system culture or a costly and complex accreditation process?
The crux of the opioid crisis is in unchecked, inappropriate prescribing habits. Absent of comprehensive medically responsible prescribing standards, today’s opioid issue has the potential to evolve into another prescription drug crisis. Are narrow legislative bills enough to keep injured workers safe and encourage a paradigm shift among prescribers?
The U.S. House of Representatives has held numerous information-gathering meetings. The divide that exists between state and federal government has never been more clear as the feds turn their focus on the success that state workers’ compensation systems are having in the war on opioid abuse. But, are all aspects of the crisis being considered?
Pennsylvania, who is hosting one of the fiercest battles in the war on opioids, will not adopt a nationally recognized evidence-based medicine drug formulary. Is this the outcome of Pennsylvania politics, the right move to preserve the doctor to patient relationship?
The importance of the National Guideline Clearinghouse™ (NGC) cannot be validated by someone continuing the work. Its importance was established in 2008 by U.S. Congress. Without appropriate oversight in the development of this content, anything might be called “quality” imperiling the well-being of injured workers. Here is my take on why “WorkComp Needs Quality Measures for Clinical Practice Guidelines”.